Cargando…

Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors

Image-guided percutaneous ablation methods have been further developed during the recent two decades and have transformed the minimally invasive and precision features of treatment options targeting primary and metastatic tumors. They work by percutaneously introducing applicators to precisely destr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansur, Arian, Garg, Tushar, Shrigiriwar, Apurva, Etezadi, Vahid, Georgiades, Christos, Habibollahi, Peiman, Huber, Timothy C., Camacho, Juan C., Nour, Sherif G., Sag, Alan Alper, Prologo, John David, Nezami, Nariman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221861/
https://www.ncbi.nlm.nih.gov/pubmed/35741109
http://dx.doi.org/10.3390/diagnostics12061300
_version_ 1784732729530646528
author Mansur, Arian
Garg, Tushar
Shrigiriwar, Apurva
Etezadi, Vahid
Georgiades, Christos
Habibollahi, Peiman
Huber, Timothy C.
Camacho, Juan C.
Nour, Sherif G.
Sag, Alan Alper
Prologo, John David
Nezami, Nariman
author_facet Mansur, Arian
Garg, Tushar
Shrigiriwar, Apurva
Etezadi, Vahid
Georgiades, Christos
Habibollahi, Peiman
Huber, Timothy C.
Camacho, Juan C.
Nour, Sherif G.
Sag, Alan Alper
Prologo, John David
Nezami, Nariman
author_sort Mansur, Arian
collection PubMed
description Image-guided percutaneous ablation methods have been further developed during the recent two decades and have transformed the minimally invasive and precision features of treatment options targeting primary and metastatic tumors. They work by percutaneously introducing applicators to precisely destroy a tumor and offer much lower risks than conventional methods. There are usually shorter recovery periods, less bleeding, and more preservation of organ parenchyma, expanding the treatment options of patients with cancer who may not be eligible for resection. Image-guided ablation techniques are currently utilized for the treatment of primary and metastatic tumors in various organs including the liver, pancreas, kidneys, thyroid and parathyroid, prostate, lung, bone, and soft tissue. This article provides a brief review of the various imaging modalities and available ablation techniques and discusses their applications and associated complications in various organs.
format Online
Article
Text
id pubmed-9221861
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92218612022-06-24 Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors Mansur, Arian Garg, Tushar Shrigiriwar, Apurva Etezadi, Vahid Georgiades, Christos Habibollahi, Peiman Huber, Timothy C. Camacho, Juan C. Nour, Sherif G. Sag, Alan Alper Prologo, John David Nezami, Nariman Diagnostics (Basel) Review Image-guided percutaneous ablation methods have been further developed during the recent two decades and have transformed the minimally invasive and precision features of treatment options targeting primary and metastatic tumors. They work by percutaneously introducing applicators to precisely destroy a tumor and offer much lower risks than conventional methods. There are usually shorter recovery periods, less bleeding, and more preservation of organ parenchyma, expanding the treatment options of patients with cancer who may not be eligible for resection. Image-guided ablation techniques are currently utilized for the treatment of primary and metastatic tumors in various organs including the liver, pancreas, kidneys, thyroid and parathyroid, prostate, lung, bone, and soft tissue. This article provides a brief review of the various imaging modalities and available ablation techniques and discusses their applications and associated complications in various organs. MDPI 2022-05-24 /pmc/articles/PMC9221861/ /pubmed/35741109 http://dx.doi.org/10.3390/diagnostics12061300 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mansur, Arian
Garg, Tushar
Shrigiriwar, Apurva
Etezadi, Vahid
Georgiades, Christos
Habibollahi, Peiman
Huber, Timothy C.
Camacho, Juan C.
Nour, Sherif G.
Sag, Alan Alper
Prologo, John David
Nezami, Nariman
Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors
title Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors
title_full Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors
title_fullStr Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors
title_full_unstemmed Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors
title_short Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors
title_sort image-guided percutaneous ablation for primary and metastatic tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221861/
https://www.ncbi.nlm.nih.gov/pubmed/35741109
http://dx.doi.org/10.3390/diagnostics12061300
work_keys_str_mv AT mansurarian imageguidedpercutaneousablationforprimaryandmetastatictumors
AT gargtushar imageguidedpercutaneousablationforprimaryandmetastatictumors
AT shrigiriwarapurva imageguidedpercutaneousablationforprimaryandmetastatictumors
AT etezadivahid imageguidedpercutaneousablationforprimaryandmetastatictumors
AT georgiadeschristos imageguidedpercutaneousablationforprimaryandmetastatictumors
AT habibollahipeiman imageguidedpercutaneousablationforprimaryandmetastatictumors
AT hubertimothyc imageguidedpercutaneousablationforprimaryandmetastatictumors
AT camachojuanc imageguidedpercutaneousablationforprimaryandmetastatictumors
AT noursherifg imageguidedpercutaneousablationforprimaryandmetastatictumors
AT sagalanalper imageguidedpercutaneousablationforprimaryandmetastatictumors
AT prologojohndavid imageguidedpercutaneousablationforprimaryandmetastatictumors
AT nezaminariman imageguidedpercutaneousablationforprimaryandmetastatictumors